3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide
C14H27N3O2 — CID 168749141
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide
3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide (PubChem CID 168749141) has the molecular formula C14H27N3O2 and a molecular weight of 269.39 g/mol. Its IUPAC name is 3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide.
Molecular Properties
| Compound Name | 3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide |
|---|---|
| PubChem CID | 168749141 |
| Molecular Formula | C14H27N3O2 |
| Molecular Weight | 269.39 g/mol |
| Exact Mass | 269.21 |
| IUPAC Name | 3-[4-(4-methylpentyl)piperidin-1-yl]-3-oxopropanehydrazide |
| SMILES | CC(C)CCCC1CCN(C(=O)CC(=O)NN)CC1 |
| InChI | InChI=1S/C14H27N3O2/c1-11(2)4-3-5-12-6-8-17(9-7-12)14(19)10-13(18)16-15/h11-12H,3-10,15H2,1-2H3,(H,16,18) |
| InChIKey | BKEUAXUGNADYJF-UHFFFAOYSA-N |
| XLogP | 1.43 |
| TPSA | 75.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 269.39 |
| LogP ≤ 5 | 1.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyl_hydrazine', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168749141 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.